Schwab Charles Investment Management Inc. increased its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 4.7% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,864,744 shares of the pharmacy operator’s stock after buying an additional 128,391 shares during the period. Schwab Charles Investment Management Inc.’s holdings in Walgreens Boots Alliance were worth $237,917,000 as of its most recent filing with the SEC.

Several other hedge funds also recently added to or reduced their stakes in the stock. Tompkins Financial Corp raised its position in shares of Walgreens Boots Alliance by 5.1% in the first quarter. Tompkins Financial Corp now owns 41,578 shares of the pharmacy operator’s stock worth $3,503,000 after buying an additional 2,007 shares in the last quarter. Atria Investments LLC raised its position in shares of Walgreens Boots Alliance by 16.3% in the first quarter. Atria Investments LLC now owns 19,465 shares of the pharmacy operator’s stock worth $1,617,000 after buying an additional 2,733 shares in the last quarter. AMI Asset Management Corp raised its position in shares of Walgreens Boots Alliance by 20.1% in the first quarter. AMI Asset Management Corp now owns 406,545 shares of the pharmacy operator’s stock worth $33,764,000 after buying an additional 67,992 shares in the last quarter. Horrell Capital Management Inc. raised its position in shares of Walgreens Boots Alliance by 0.4% in the first quarter. Horrell Capital Management Inc. now owns 28,010 shares of the pharmacy operator’s stock worth $2,326,000 after buying an additional 100 shares in the last quarter. Finally, TNB Financial acquired a new position in shares of Walgreens Boots Alliance during the first quarter worth $265,000. Institutional investors own 61.17% of the company’s stock.

Shares of Walgreens Boots Alliance, Inc. (WBA) traded up 1.22% during midday trading on Friday, reaching $80.72. The company had a trading volume of 3,992,347 shares. Walgreens Boots Alliance, Inc. has a 52 week low of $75.18 and a 52 week high of $89.69. The firm has a market capitalization of $86.38 billion, a price-to-earnings ratio of 20.38 and a beta of 1.25. The stock has a 50-day moving average of $79.08 and a 200 day moving average of $82.30.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.30 by $0.03. The company had revenue of $30.12 billion during the quarter, compared to analyst estimates of $29.72 billion. Walgreens Boots Alliance had a return on equity of 17.34% and a net margin of 3.69%. The firm’s revenue was up 2.1% on a year-over-year basis. During the same quarter last year, the business posted $1.18 earnings per share. On average, analysts anticipate that Walgreens Boots Alliance, Inc. will post $5.01 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 12th. Investors of record on Friday, August 18th will be given a $0.40 dividend. The ex-dividend date of this dividend is Wednesday, August 16th. This represents a $1.60 annualized dividend and a yield of 1.98%. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 37.78%.

Walgreens Boots Alliance declared that its board has approved a stock buyback program on Thursday, June 29th that authorizes the company to repurchase $5.00 billion in shares. This repurchase authorization authorizes the pharmacy operator to buy up to 5.9% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company’s management believes its stock is undervalued.

COPYRIGHT VIOLATION WARNING: “Schwab Charles Investment Management Inc. Has $237.92 Million Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)” was first published by Watch List News and is the sole property of of Watch List News. If you are viewing this report on another website, it was stolen and reposted in violation of U.S. and international copyright law. The legal version of this report can be accessed at https://www.watchlistnews.com/schwab-charles-investment-management-inc-has-237-92-million-position-in-walgreens-boots-alliance-inc-nasdaqwba/1479074.html.

A number of equities analysts have weighed in on the company. Zacks Investment Research lowered Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Wednesday, June 14th. BidaskClub upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Thursday, August 3rd. Jefferies Group LLC decreased their target price on Walgreens Boots Alliance from $95.00 to $80.00 and set a “buy” rating on the stock in a research note on Wednesday, May 31st. Needham & Company LLC set a $94.00 target price on Walgreens Boots Alliance and gave the stock a “buy” rating in a research note on Monday, July 17th. Finally, Guggenheim restated a “buy” rating on shares of Walgreens Boots Alliance in a research note on Monday, July 3rd. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and fourteen have issued a buy rating to the stock. Walgreens Boots Alliance presently has a consensus rating of “Buy” and a consensus target price of $90.69.

In related news, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction dated Tuesday, July 25th. The stock was sold at an average price of $79.79, for a total value of $218,305.44. Following the completion of the transaction, the director now owns 19,151 shares in the company, valued at $1,528,058.29. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 13.50% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.